Fat metabolism research fragment
AOD-9604.
3 vendors · CA$56–60
Modified C-terminal fragment of human growth hormone (hGH 177–191). Researched for adipose-tissue mechanisms; not approved for human therapeutic use.
Live vendor register · grouped by strength
Every vendor. Cheapest per mg first, kits listed separately.
AOD-9604 · price per mg
3 listings · unflagged vendors first · Listings data last updated October 2026
Best price per mg: Pepsup 5 mg at CA$11.20/mg.
5 mg
2 listings01
PepsupVID-PEPSUP · €34.99 · duties on delivery
5 mg
99%
No COA published (mfr claim 99%+)
In stock
NL dispatch · PostNL Tracked 2–5 business days
CA$11.20/mg
CA$56
02
Polar PeptidesVID-POLAR-PE · CA domestic
5 mg
99.95%
HPLC-UV only · Testides report HS1-AOD-5mg-051126-02, 2026-05-18 · no mass-spec identityTestides · HPLC-UV · Batch HS1-AOD-5mg-051126-02 · May 18, 2026 · Verify COA ↗
In stock
2–10 days
CA$12.00/mg
CA$60
Flagged vendors · documented, never recommended
01
Peptide WarehouseVID-PEPTIDE- · ON warehouse
5 mg
99.4%
Prism Analytical Laboratory certificate (HPLC-MS/MS, net content, metals, LAL), lab unverifiable (no address or accreditation; prismlabs.ca registered 2026-09-08; printed verify address prismlab.com/verify is an unrelated company's 404) · report 89EDDB, lot 4890P, issued 2026-09-24Prism Analytical Laboratory · Batch 4890P · Sep 24, 2026 · Verify COA ↗
In stock
1–5 days
CA$10.00/mg
CA$50
Same research area
Similar compounds.
GH secretagogue research
Ipamorelin
Synthetic pentapeptide described in 1998 by Novo Nordisk researchers as a selective ghrelin/GH-secretagogue receptor agonist; researched for growth-hormone release. Not approved for human therapeutic use.
4 vendorsCA$24–100
GHRH analogue research
CJC-1295
GHRH(1-29) analogue developed by ConjuChem; the DAC form binds albumin and persists for days, the no-DAC form (Mod GRF 1-29) is short-acting. Researched for GH/IGF-1 stimulation; not approved for human therapeutic use.
4 vendorsCA$48–86
GLP-1 receptor agonist research
Semaglutide
GLP-1 receptor agonist, FDA- and EMA-approved as Ozempic, Wegovy and Rybelsus. Research-vial semaglutide is a different, unapproved product, not made or reviewed as those medicines, and not for human use.
1 vendorCA$80
GIP/GLP-1 dual agonist research
Tirzepatide
Dual GIP/GLP-1 receptor agonist, FDA- and EMA-approved as Mounjaro and Zepbound. Research-vial tirzepatide is a different, unapproved product, not made or reviewed as those medicines, and not for human use.
1 vendorCA$145
Triple hormone agonist research
Retatrutide
Investigational triple GIP/GLP-1/glucagon receptor agonist (LY3437943) developed by Eli Lilly and studied in Phase 3 trials; not approved as a medicine anywhere and not for human therapeutic use.
1 vendorCA$112
Long-form research guide
Weight Loss Research. Mechanism + protocols + safety.
Lipolysis, GH secretagogues, and adipose tissue modulation in obesity models
Open the long-form guide for AOD-9604 →